Victoria M Raymond Selected Research

Circulating Tumor DNA

1/2022	Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors.
1/2022	Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
11/2021	Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
10/2021	Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.
1/2021	Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
11/2020	Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
1/2020	Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.
12/2019	Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
10/2019	Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations.
10/2019	Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria M Raymond Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 03/2011
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 12/2019
2	Stomach Neoplasms (Stomach Cancer) 12/2019 - 01/2019
1	Cholangiocarcinoma 01/2022
1	Diarrhea 11/2021
1	Residual Neoplasm 10/2021
1	Appendiceal Neoplasms (Appendix Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Microsatellite Instability 12/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Urogenital Neoplasms 01/2019
1	Peritoneal Neoplasms 08/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Adenocarcinoma 11/2017
1	Paraganglioma (Paragangliomas) 08/2014
1	Hereditary leiomyomatosis and renal cell cancer 03/2012
1	Kidney Neoplasms (Kidney Cancer) 03/2012
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2011

Drug/Important Bio-Agent (IBA)

20	Circulating Tumor DNAIBA 01/2022 - 01/2017
10	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 08/2014
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2019
2	HM781-36BIBA 03/2020 - 10/2019
2	NucleotidesIBA 01/2020 - 10/2019
2	Biological ProductsIBA 12/2019 - 08/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Pharmaceutical PreparationsIBA 10/2019
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	NivolumabIBA 01/2018
1	CarbohydratesIBA 11/2017
1	AntigensIBA 11/2017
1	RNA (Ribonucleic Acid)IBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2014
1	Indicators and Reagents (Reagents)IBA 03/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 04/2016
4	Precision Medicine 01/2020 - 08/2014
1	Immunotherapy 12/2019
1	Molecular Targeted Therapy 11/2018
1	Prostatectomy (Retropubic Prostatectomy) 03/2011